Characterization of tumor immune cell infiltration in BRCA-ness demonstrated an association with suppressive tumor associated TREM2 macrophages expressing marker genes, such as LILRB4 and ITGB2, which were found to be downregulated by combination therapy. Here, LILRB4 is linked to neoplasm.